Literature DB >> 7511560

The extracellular matrix in pigmented skin lesions: an immunohistochemical study.

C M Van Duinen1, G J Fleuren, J A Bruijn.   

Abstract

In recent years the interaction between tumour cells and the surrounding extracellular matrix in the process of tumour development, invasion and metastasis has been a focus of interest. We studied frozen sections of nine naevocellular naevi (junctional, compound and intradermal), 40 dysplastic naevi, six pagetoid in situ melanomas and 12 superficial spreading melanomas in order to determine the expression of: the basement membrane proteins collagen type IV and laminin, the interstitial collagen types I, III and VI, and fibronectin and tenascin. An indirect immunoperoxidase technique was used. In the various stages of melanocytic tumour progression we observed: 1 loss of type IV collagen and laminin within dermal melanocytic cell nests; 2 de novo expression of basement membrane type IV collagen and increased expression of the interstitial collagen types I, III and VI, as well as tenascin and fibronectin in the dermal stroma surrounding dysplastic naevus cells and melanoma cells; 3 presence of extracellular matrix components in close association with intra-epidermally located invading atypical melanocytes. These data demonstrate the complex alterations of the composition of the extracellular matrix from bland naevi through lesions with progressive atypia to invasive melanoma. The changes described result in a molecular environment which melanocytes with an altered adhesion molecule profile are able to invade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511560     DOI: 10.1111/j.1365-2559.1994.tb01268.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Immunohistological distribution of heparan sulfate proteoglycan and chondroitin 6-sulfate in carcinomas with eccrine differentiation.

Authors:  T Kazama; M Isemura; T Nakamura; M Ito
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

2.  Integrin adjunct therapy for melanoma.

Authors:  Kumari L Andarawewa; Konstadinos Moissoglu; Chang Sup Lee; Yuta Ando; Min Yu; Prianka Debnath; John D Shannon; Suseela Sirinivasan; Mark R Conaway; Michael J Weber; Martin A Schwartz
Journal:  Pigment Cell Melanoma Res       Date:  2014-11-03       Impact factor: 4.693

Review 3.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

4.  'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.

Authors:  Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Exp Ther Med       Date:  2011-02-28       Impact factor: 2.447

Review 5.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

6.  Malignant melanoma and its stromal nonimmune microecosystem.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  J Oncol       Date:  2012-06-28       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.